Summary
This narrative review outlines essential echocardiographic imaging considerations for post-implantation evaluation of the transcatheter EVOQUE tricuspid valve replacement system, an approved device for symptomatic severe tricuspid regurgitation refractory to medical therapy. The review synthesises imaging protocols required to assess device positioning, haemodynamic performance, and procedure-related complications including residual regurgitation, paravalvular leak, and interactions with adjacent cardiac structures. The guidance aims to standardise post-procedural echocardiographic assessment protocols in clinical practice.
Regional applicability
This review addresses imaging requirements for a device approved in both the United States and Europe, including the United Kingdom. The echocardiographic assessment protocols outlined are likely applicable to UK practice, though implementation would depend on adoption of the EVOQUE system within the National Health Service and specialist cardiac centres.
Key measures
Echocardiographic assessment of device positioning and stability, residual tricuspid regurgitation, paravalvular leak, valve thrombosis/degeneration, device–right ventricular interaction, and pacemaker lead placement
Outcomes reported
The paper reviews echocardiographic imaging protocols for post-implantation assessment of the EVOQUE tricuspid valve replacement system, focusing on device positioning, stability, and complications.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.